• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Roger Stupp, Eric T. Wong, +32 authors Philip H. Gutin
  • Medicine
  • European journal of cancer
  • 2012 (First Publication: 1 September 2012)
  • PURPOSE NovoTTF-100A is a portable device delivering low-intensity, intermediate frequency electric fields via non-invasive, transducer arrays. Tumour Treatment Fields (TTF), a completely newContinue Reading
  • Kent Wallner, Joseph H. Galicich, George Krol, Ehud Arbit, Mark G. Malkin
  • Medicine
  • International journal of radiation oncology…
  • 1989 (First Publication: 1 June 1989)
  • Recurrence patterns of glioblastoma multiforme (25) and anaplastic astrocytoma (9) were studied using CT scans of 34 patients who received all or a portion of their surgical treatment at MemorialContinue Reading
  • Kathleen M. Schmainda, M A Prah, +4 authors Mark G. Malkin
  • Medicine
  • Neuro-oncology
  • 2014 (First Publication: 1 June 2014)
  • BACKGROUND The anti-VEGF antibody, bevacizumab, is standard treatment for patients with recurrent glioblastoma. In this setting, traditional anatomic MRI methods such as post-contrast T1-weighted andContinue Reading
  • Peter S. LaViolette, Nikolai J Mickevicius, +6 authors Kathleen M. Schmainda
  • Medicine
  • Neuro-oncology
  • 2014 (First Publication: 1 December 2014)
  • BACKGROUND Recent conflicting reports have found both brain tumor hypercellularity and necrosis in regions of restricted diffusion on MRI-derived apparent diffusion coefficient (ADC) images. ThisContinue Reading
  • James Perry, Jim A. Julian, +10 authors Mark Norman Levine
  • Medicine
  • Journal of thrombosis and haemostasis : JTH
  • 2010 (First Publication: 1 September 2010)
  • BACKGROUND AND OBJECTIVES Venous thromboembolism (VTE) occurs in 20-30% of patients with malignant glioma per year of survival. We tested the efficacy of long-term dalteparin low-molecular-weightContinue Reading